NUMEKLI Trademark
Trademark Overview
On Wednesday, September 27, 2023, a trademark application was filed for NUMEKLI with the United States Patent and Trademark Office. The USPTO has given the NUMEKLI trademark a serial number of 98200111. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 9, 2026. This trademark is owned by Rosemont Pharmaceuticals Limited. The NUMEKLI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid f...
General Information
| Serial Number | 98200111 |
| Word Mark | NUMEKLI |
| Filing Date | Wednesday, September 27, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Rosemont Pharmaceuticals Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Leeds LS119XE
GB |
| Party Name | Rosemont Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Leeds LS119XE
GB |
Trademark Events
| Event Date | Event Description |
| Saturday, September 30, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 20, 2024 | ASSIGNED TO EXAMINER |
| Monday, May 20, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, May 20, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, May 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 5, 2024 | ASSIGNED TO LIE |
| Tuesday, November 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 7, 2024 | SUSPENSION LETTER WRITTEN |
| Thursday, November 7, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, November 7, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, May 8, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, November 11, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, May 11, 2026 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, May 11, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 3, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 9, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 9, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
